Dave Ross
Partner
Agrifood Investment Advisory LLP
Emily Don
Head of Sustainability
Avara Foods
Judith Batchelar
Director
Food Matters International Ltd
Michael Birshan
Senior Partner
McKinsey & Co.
McKinsey & Company
Website: http://www.mckinsey.com/
McKinsey is a global management consulting firm committed to helping organizations accelerate sustainable and inclusive growth. We work with clients across the private, public, and social sectors to solve complex problems and create positive change for all their stakeholders. We combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next.
Linda Rhodes
VMD, PhD, Independent and ex-CSO
Independent Animal Health
Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.
Louise Grubb
CEO & Co-Founder
TriviumVet
Paul Dick
President
Paul Dick & Associates
Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.
While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.
His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.
Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.
In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).
Stephen Murray, DVM
Associate Vice President, Animal Health Ventures
MSD Animal Health
Pedro Silva, DVM
Vice President, North West – EURAM Region
MSD Animal Health
Fergal Morris, DVM
Managing Director, Ireland
MSD Animal Health
Christine Royal, DVM
Vice President, U.S. Companion Animal and Equine Business Unit
MSD Animal Health
This opening discussion takes a bird’s eye look at the landscape, examining whether a centralised approach
towards women’s health will play a pivotal role in overcoming the fragmentation of EU healthcare &
reimbursement to accelerate innovation & investment and improve outcomes. Hear from industry experts as
they discuss the impact of the 2024 European Parliamentary Elections, and the European Institute of Women’s
Health’s EU Manifesto for Women’s Health in driving policy changes and consider the impact that the EU4Health
Programme has in championing EU Financial support of healthcare. Taking a comparative approach, panellists
will assess what the Women’s Health Strategy for England has contributed towards innovation and research, and
whether it is a replicable model for the EU.
Beatrice Lemberg, Senior Director of Marketing, Hologic
Beatrice Lemberg
Senior Director of Marketing
Hologic
Beatrice Lemberg
Senior Director of Marketing
Hologic
As the Biotech hub of the world, Europe is fertile ground for disruptive research set to transform women’s
health innovation. But how do we champion early-stage clinical development and research and better
translate it into outcomes? How can research and development be better incubated and accelerated?
What strategies should be adopted to ensure that life science innovation and therapeutic solutions are
being prioritized? What are large pharmaceutical companies looking for, and what are some examples
partnerships in the space? Join this opening discussion to unpack these questions, and hearing from
examples of partnerships responsible for leading the way.
Marco Rüedi, Mentor, Tech4Eva, Senior Business Coach,EPFL Innovation Park
Trine Bartholdy, Chief Innovation Officer, BioInnovation Institute
Marco Rüedi, MD
Mentor, Tech4Eva, and Senior Business Coach
EPFL Innovation Park
Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management.
He is a strong believer in well-balanced teams: motivated to challenge the status quo! Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.
He holds a Medical Doctor from the University of Fribourg, Berne and Zurich, an Executive Masters in Medical Management from eMMM PHW Bern, and an Executive Masters in Business Administration from eMBA PHW Bern.
Trine Bartholdy
Chief Innovation Officer
BioInnovation Institute
